Table 3.
Baseline characteristics of participants. Values are numbers (percentages) of women unless stated otherwise
| Characteristic | Intervention group (n=103) | Control group (n=102) |
|---|---|---|
| Mean age (years) | 50.75 | 50.11 |
| Ethnicity (white) | 95 (92) | 93 (93) |
| Educational attainment: | ||
| Up to secondary education | 40 (39) | 24 (24) |
| Beyond secondary education | 63 (61) | 78 (77) |
| Treatment choice for hormone replacement therapy: | ||
| To take | 31 (30) | 27 (27) |
| Not to take | 21 (20) | 18 (18) |
| Let doctor decide | 4 (4) | 5 (5) |
| Unsure | 47 (46) | 51 (51) |
| Mean (SD) MenQol score: | ||
| Vasomotor | 2.71 (1.73) | 3.02 (2.0) |
| Psychosocial | 3.55 (1.82) | 3.65 (1.81) |
| Physical | 3.42 (1.33) | 3.47 (1.35) |
| Sexual | 2.85 (2.16) | 2.34 (1.62) |
| Mean (SD) decisional conflict score: | ||
| Uncertainty | 3.61 (0.73) | 3.69 (0.87) |
| Factors contributing to uncertainty | 2.70 (0.45) | 2.65 (0.46) |
| Mean (SD) score on Spielberger state trait anxiety inventory | 38.87 (12.34) | 38.73 (13.18) |